跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Alfuzosin PH&T 10mg prolonged-release tablets - HSA Drug Approval Details
Approvals
/
HSA
/
Alfuzosin PH&T 10mg prolonged-release tablets
Approved
THERAPEUTIC
Alfuzosin PH&T 10mg prolonged-release tablets
MIPHARM S.P.A
🇸🇬 Health Sciences Authority
Approval Date
Jun 21, 2010
Approval ID
c418b93df03cfc39
Company
MIPHARM S.P.A
Type
Therapeutic
Approval Details
Approval Id
c418b93df03cfc39
Drug Name
Alfuzosin PH&T 10mg prolonged-release tablets
Product Name
Alfuzosin PH&T 10mg prolonged-release tablets
Approval Number
SIN13819P
Approval Date
2010-06-21
Registrant
NOVEM HEALTHCARE PTE LTD
Licence Holder
NOVEM HEALTHCARE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
G04CA01
Atc Item Name
alfuzosin
Pharma Manufacturer Name
NOVEM HEALTHCARE PTE LTD
Company Detail Path
/organization/novem-healthcare-pte-ltd
Active Ingredients
Alfuzosin hydrochloride
10.000 mg
ALFUZOSIN HYDROCHLORIDE
10 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 21, 2010
Approval ID
c418b93df03cfc39
Type
Therapeutic
Back to HSA Approvals
